ASTRAZEN
Invest with MTF
Invest Now
Invest in AstraZeneca Pharma India with 3.26X leverage
Performance
- Low
- ₹8,601
- High
- ₹8,710
- 52 Week Low
- ₹6,620
- 52 Week High
- ₹10,691
- Open Price₹8,601
- Previous Close₹8,600
- Volume3,010
- 50 DMA₹8,684.88
- 100 DMA₹8,793.20
- 200 DMA₹8,636.24
Investment Returns
- Over 1 Month + 2.99%
- Over 3 Month -4.49%
- Over 6 Month -1.3%
- Over 1 Year + 13.9%
Smart Investing Starts Here Start SIP with AstraZeneca Pharma India for Steady Growth!
AstraZeneca Pharma India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 108.8
- PEG Ratio
- 0.8
- Market Cap Cr
- 21,675
- P/B Ratio
- 27.1
- Average True Range
- 186.94
- EPS
- 92.47
- Dividend Yield
- 0.4
- MACD Signal
- -69.71
- RSI
- 51.79
- MFI
- 33.68
AstraZeneca Pharma India Financials
AstraZeneca Pharma India Technicals
EMA & SMA
Current Price
₹8,670.00
+
70
(0.81%)
- Bearish Moving Average 6
- Bullish Moving Average 10
- 20 Day
- ₹8,543.27
- 50 Day
- ₹8,684.88
- 100 Day
- ₹8,793.20
- 200 Day
- ₹8,636.24
Resistance and Support
8591.67
- R3 8,738.33
- R2 8,686.67
- R1 8,643.33
- S1 8,548.33
- S2 8,496.67
- S3 8,453.33
AstraZeneca Pharma India Corporate Actions - Bonus, Splits, Dividends
AstraZeneca Pharma India F&O
About AstraZeneca Pharma India
- NSE Symbol
- ASTRAZEN
- BSE Symbol
- 506820
- Managing Director
- Mr. Praveen Rao Akkinepally
- ISIN
- INE203A01020
Similar Stocks to AstraZeneca Pharma India
AstraZeneca Pharma India FAQs
AstraZeneca Pharma India share price is ₹8,670 As on 09 February, 2026 | 14:49
The Market Cap of AstraZeneca Pharma India is ₹21675 Cr As on 09 February, 2026 | 14:49
The P/E ratio of AstraZeneca Pharma India is 108.8 As on 09 February, 2026 | 14:49
The PB ratio of AstraZeneca Pharma India is 27.1 As on 09 February, 2026 | 14:49
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.